What is the revenue and EPS growth rate for Bank OZK Pref A year over year?

What is the market's earnings forecast for Bank OZK Pref A next quarter?

What factors drove the changes in Bank OZK Pref A's revenue and profit?

What is Bank OZK Pref A's gross profit margin?

What were the key takeaways from Bank OZK Pref A’s earnings call?

Did Bank OZK Pref A beat or miss consensus estimates last quarter?

What were the key takeaways from Bank OZK Pref A's earnings call?

What is Bank OZK Pref A's latest dividend and current dividend yield?

- **CRE Cycle Near Resolution**: 2026 expected to mirror 2024-2025, with 2027 showing improvement. ACL at $632M absorbs risks, with ~95% of RESG loans supported by sponsors.
- **Fee Income Growth Accelerating**: CIB initiatives (hedging, syndications) and mortgage lending to drive incremental 2026 growth, with 2027 impact from wealth and private banking.
- **Asset Resolution Progress**: 3 of 4 nonaccrual assets resolved in 2025. Boston property and San Diego life sciences projects show dual-track resolution and sponsor commitment.
- **Margin Resilience**: Q4 margin held despite rate cuts; buyback activity supports shareholder returns with $100M remaining authorization.

**【Management Opening Remarks】**
- Jay Staley provided an overview of the call, emphasizing forward-looking statements and the availability of supporting documents for risk factors.
- Key executives, including George Gleason (CEO), Paschall Hamblen (President), and Tim Hicks (CFO), were introduced to answer questions.

**【Loan Sales and Credit Outlook】**
- **Loan Sale Context**: The sale of a single credit at par was a one-off event, not a strategic shift. Historical note sales have been rare and situational (e.g., Lincoln Yards project).
- **CRE Cycle Progress**: Management expects 2026 to mirror 2024-2025, with the CRE cycle nearing resolution. Green shoots in leasing, refinancing, and liquidity suggest late-stage recovery.
- **Credit Resilience**: ACL was prudently built to $632 million, absorbing charge-offs while maintaining strong sponsor support (~95% of RESG loans). 2027 outlook is optimistic with improving sponsor conditions.

**【Fee Income Growth Strategy】**
- **CIB Expansion**: Corporate Services (loan syndications, hedging) and mortgage lending are key growth drivers. Noninterest income is expected to grow incrementally in 2026 and accelerate in 2027.
- **Wealth and Private Banking**: Trust/wealth and private banking initiatives aim to diversify revenue. Treasury management services are being enhanced for institutional clients.

**【CRE Cycle and Asset Resolution】**
- **Life Sciences Recovery**: Slow but steady progress in leasing, driven by AI demand in tech hubs. Sponsors remain committed, with 49 loans benefiting from $56.7 million in reserve deposits and $45.1 million in paydowns.
- **Office Market Strength**: Mixed-use projects show liquidity, with 4 office refinances in Q4. Flight-to-quality trends persist, supporting high-grade assets.
- **Asset Resolution Progress**: 3 of 4 nonaccrual RESG assets resolved in 2025. Remaining assets are being actively managed, with potential for sale or lease-up.

**【Credit Metrics and Reserve Management】**
- **ACL Dynamics**: ACL decreased to $632 million (from $680 million) as resolved assets reduced reserves. 2026 NCOs expected to align with 2025 levels (~50bps), with ACL potentially easing as the cycle closes.
- **Special Mention Fluidity**: Special mention loans often revert to pass status post-negotiation. Substandard migration is case-specific, with ACL preparedness mitigating risks.

**【Buyback Activity and Margin Performance】**
- **Share Repurchases**: $100 million buyback completed in Q4 at $44.45, below tangible book. Remaining $100 million authorization will be opportunistic, expiring in June 2026.
- **Net Interest Margin**: Q4 margin held due to SOFR declines and deposit cost management. Q1 2026 faces day-count headwinds, but margin management remains a priority.

**【Specific Asset Updates】**
- **Boston Property**: Sponsor support waned, leading to as-is appraisal. Dual-track resolution includes sponsor recap or asset acquisition. Prospective tenant decision delayed to mid-2026.
- **San Diego Life Sciences**: New management team with $900 million capital raise. Activation of leased space expected in H1 2026, with tenant improvements nearing completion.
- **Baltimore Land**: Sale discussions ongoing, with potential for development collaboration with current sponsor.

Bank OZK (OZK) Q4 2025 Earnings Call Transcript

- **Credit Resilience**: Largest OREO sale at book value; 41 loan extensions with $70M in new reserves highlight strong sponsor support.
- **Loan Growth Catalysts**: Mid-single-digit 2026 growth via CIB diversification (30-40% target) and 2027 RESG recovery.
- **Margin Stability**: 22% of loans at floor; NII compression lagging Fed cuts by 2-3 quarters, but 7-month CD repricing will follow.
- **CIB Expansion**: $1.6B Q3 origination; fee income growth offsetting lower yields, with selective talent additions.

**【CEO Summary Section】**
- **Credit Quality and Asset Resolution**: Despite 3 loan migrations to substandard, the company resolved its largest foreclosed asset at book value and expects neutral to positive gains on two other OREO sales. Sponsor support remained strong, with 41 loan extensions/modifications and $70M in additional reserves.
- **Loan Growth Outlook**: Mid-single-digit loan growth expected in 2026, driven by CIB diversification (targeting 30-40% of loan book by 2027). RESG payoff wave will ease in 2027, enabling balanced growth across RESG, CIB, and indirect banking.
- **Margin Dynamics**: NIM compression due to Fed cuts will lag 2-3 quarters, but 22% of variable loans at floor as of Q3, limiting downside. Deposit repricing (7-month CDs) will follow 7 months after rate cuts.
- **CIB Expansion**: CIB originated $1.6B in net new business Q3, with focus on high utilization, low unfunded loans. Fee income from capital markets (e.g., bond issuance) is growing, offsetting lower yields.

**【CFO Financial Commentary】**
- **Q3 2025 Results**: Net interest income (NII) guidance for Q4 reflects Fed cuts and loan repricing. Fee income growth from CIB and capital markets offsets margin compression. 
- **Credit Metrics**: Non-performing assets (NPAs) stable at 0.35%, with 41% of loans at floor limiting further migration. Charge-offs were concentrated in identified risks, with strong reserve coverage.

**【Q&A Key Highlights】**
- **Boston Loan Update**: Sponsor actively pursuing a 1/3 lease win, with reserve reflecting wide outcome range. Management confident in sponsor support despite challenges.
- **CIB Strategy**: CIB teams are adding high-quality talent selectively, with gating metrics ensuring expense discipline. Fee income as a percentage of revenue is expected to rise as CIB scales.
- **2026-2027 Outlook**: 2026 EPS growth will be modest due to payoff wave, but 2027 should see acceleration with CIB and RESG growth engines firing. Share buybacks may increase as unfunded book shrinks.

Bank OZK (OZK) Q3 2025 Earnings Call Transcript

- **CIB Growth Acceleration**: Q2 loan growth of 10.1%, with CIB driving 12% pull-through on $7 billion opportunities.
- **Branch Expansion**: 11 new branches in 2025, 25 planned for 2026, supporting deposit growth.
- **RESG Repayments**: $0.54 billion in Q2, offsetting growth with cautious outlook on 2026.
- **Risk Management**: $366 million ALLL build over 12 quarters, maintaining 1/3 industry charge-off ratio.
- **Strategic Initiatives**: Expansion of Natural Resource Group and CBSF to diversify lending.

**【New Hires and Branch Expansion】**
- Added 109 FTEs in Q2, with 11 branches opened this year, 14 more planned for 2025, and 25 for 2026. Expansion includes business banking teams in Florida, Texas, and Georgia.

**【Loan Growth Outlook】**
- Year-to-date loan growth of 10.1%, with full-year guidance of 11-13%. CIB (Corporate & Institutional Banking) is the primary growth driver, while RESG (Real Estate Specialized Group) faces $0.54 billion in Q2 repayments.

**【Deposit Performance】**
- Q2 deposits grew by $1.6 billion, with stable costs due to Federal Reserve rates. Branch expansion supports long-term deposit growth.

**【CIB Strategic Growth】**
- CIB approved $7 billion in opportunities, with a 12% pull-through rate, focusing on high-quality deals and relationship banking. Natural Resource Group and CBSF (Corporate Banking & Sponsor Finance) are key growth initiatives.

**【Risk Management】**
- Special mention loans increased by $176 million, reflecting normal portfolio adjustments. Allowance for loan losses (ALLL) built $366 million over 12 quarters, maintaining a cautious outlook.

**【Appraisal and LTV Trends】**
- 98% of loans reappraised, with LTV rising 2% to 45%. Life science and multifamily projects show gradual leasing activity, though challenges remain.


Bank OZK (OZK) Q2 2025 Earnings Call Transcript

- **Loan Growth Strategy**: 2025 loan growth expected at mid-single to high single digits, with CIB offsetting RESG uncertainty. Non-RESG loans drove 65% of recent growth.
- **CIB Expansion**: Robust pipelines in ABLG and CBSF; natural resources group launching this year. LSCS adds fee income, with credit quality as top priority.
- **Financial Performance**: Q1 NII flat due to fewer days; COIBD down 29 bps. Reinvesting securities at 5%-7% yields to support NII. Stock buybacks active at $20M post-quarter.
- **Risk Management**: ALL increased to 1.46% of loans; provisions 4x losses over 11 quarters. OREO assets show cautious optimism, with LA land contract renegotiated.
- **Key Risks**: Tariffs may slow decisions, but CIB focuses on high-quality sponsors. NII sensitive to 2 rate cuts, but 44% of loans hit floors at -50 bps.


**【CEO Summary Section】**
- **Loan Growth and Strategy**: Total loan growth for the year is expected to be mid-single to high single digits, with 3.8% growth in Q1. RESG (Real Estate Specialized Group) origination guidance was withdrawn due to market uncertainty, but CIB (Corporate and Institutional Banking) is expected to offset any shortfall. Non-RESG loans accounted for 65% of recent growth, driven by ABLG, CBSF, and new verticals like natural resources.
- **CIB Expansion**: CIB pipelines remain robust, with ABLG and CBSF leading in Q1. New teams are being added in key markets, and the natural resources group is launching this year. LSCS (Leveraged Specialized Credit Solutions) is contributing fee income. The strategy emphasizes credit quality first.
- **RESG and Uncertainty**: RESG faces headwinds from tariffs and market uncertainty, but sponsors are supportive. Lease-up activity continues, with high-quality projects performing well. The company expects elevated repayments in 2025 but remains cautious on origination volumes.

**【CFO Financial Commentary】**
- **Net Interest Income (NII)**: Q1 NII was flat quarter-over-quarter due to two fewer days in the quarter. COIBD (Cost of Interest-Bearing Deposits) decreased by 29 bps, driven by disciplined deposit management. Reinvesting maturing securities at higher rates (5%-7% tax-equivalent yield) is expected to support NII.
- **Deposit Management**: Despite a challenging environment, deposits grew with a 90 bps pickup in March. Time deposit rollovers were retained at 3.71%, 7 bps below the quarterly average. The team aims to continue reducing costs while funding growth.
- **Stock Buybacks**: Repurchased $20 million post-quarter end, with plans to remain active if the stock remains undervalued. The Board may approve a new authorization soon.

**【Risk Management and Asset Quality】**
- **Allowance for Loan Losses (ALL)**: Increased by $19 million in Q1, reflecting cautious scenarios. The ALL-to-loans ratio is 1.46%, up from 1.36% in Q4. Provisions have been 4x actual losses over 11 quarters, indicating prudent risk management.
- **OREO Assets**: The Los Angeles land contract was renegotiated, with $4 million in fees and earnest money. The project is expected to close by September 30, potentially yielding a small gain. The Chicago land loan remains under active discussion with sponsors.

**【Q&A Highlights】**
- **Tariffs and CIB Focus**: Tariffs may slow decision-making, but CIB focuses on high-quality sponsors with strong balance sheets. LTV ratios remain conservative (e.g., 51% for Maryland land loan).
- **NII Sensitivity**: Two Fed rate cuts could pressure NII, but 44% of loans hit floor rates at -50 bps, providing margin protection. Floors and time deposit repricing will mitigate risks.
- **Expense Growth**: Noninterest expense is expected to grow 10% annually, driven by branch openings (34 new branches in 2025) and CIB expansion. Teams are adding staff strategically to capitalize on opportunities.


Bank OZK (OZK)-17 Apr 25-2025 Q1 Earnings call transcript

- **CIB Growth Surpasses Expectations**: CBSF unit led Q4 originations with highest yield, targeting mid-single-digit growth in 2025. CIB's 44% LTV ratio reflects disciplined underwriting.
- **RESG Pipeline Strengthens**: Despite Q4 originations lag, signed term sheets indicate sponsor confidence in lower rates. 80%+ of loans reappraised with minimal impact on portfolio quality.
- **Rate Sensitivity**: 14% of loans at floor rates; 0-50bps rate cuts could slow NIM expansion, but 3+ cuts would benefit margins.
- **Regulatory Optimism**: Incoming admin may ease rules, supporting bank lending and reducing reliance on private credit.
- **Share Buybacks**: Expanded parameters may trigger buybacks if stock price aligns with intrinsic value.

**【CEO & CIB Growth Overview】**
- **CIB Momentum**: Q4 2024 CIB originations exceeded expectations, driven by CBSF (Corporate Banking & Sponsor Finance) with the highest yield among CIB units. The pipeline for 2025 is robust, with a focus on industrial, multifamily, and condo developments in markets like Miami, Texas, and the Carolinas.
- **Strategic Expansion**: CIB aims to replicate RESG's success in non-real estate lending, targeting mid-single-digit loan growth. The team is disciplined in hiring, ensuring new hires are pre-funded by incremental business.
- **Credit Quality**: CIB operates with a "credit first" philosophy, maintaining a conservative 44% weighted average loan-to-value ratio. Modifications (e.g., $52M+ paydowns in Q4) are viewed as positive, generating fees without concessions.

**【RESG & Rate Environment】**
- **Originations Lag**: Q4 2024 RESG originations were the lowest in 27 quarters, reflecting sponsors' cautiousness in 2023. However, the pipeline of signed term sheets is strong, driven by lower rates and a pro-business environment.
- **Paydowns & Modifications**: Elevated prepayments (e.g., $41.8M unfunded commitments reduced in Q4) and extensions (e.g., 90-day extensions for bridge financing) are expected to continue. 14% of variable-rate loans are at floor rates, with sensitivity to 0-50bps rate cuts.
- **Appraisal Progress**: 80%+ of RESG loans have been reappraised in a higher rate environment, with minimal impact on portfolio quality (43-44% LTV range).

**【Financial & Regulatory Outlook】**
- **Expense Growth**: 2025 expenses are expected to rise ~10% due to talent acquisition (e.g., retail banking, CIB teams). Efficiency ratio remains industry-leading (~35%).
- **Regulatory Optimism**: Incoming administration may ease regulatory burdens, allowing banks to meet more credit needs and reduce reliance on private credit.
- **Share Buybacks**: Repurchase parameters will expand, but activity depends on stock price. Q4 2024 was close to triggering buybacks but fell short.

**【Q&A Highlights】**
- **CIB vs. RESG Profitability**: CIB loans have lower yields but generate fees (e.g., treasury management, interest rate hedging). Over time, diversification may improve ROE by reducing CRE concentration.
- **Regulatory Changes**: Advocacy for reduced regulatory constraints to support economic growth, with potential benefits for bank lending.
- **OREO Property**: Prospective buyer's $6M earnest money was applied to the loan. Discussions continue, but remarketing is a backup plan.


Actual											0.09	0.39	0.84	0.93	1.14	1.16	1	1.17	1.02	1.1	1.08	1.34	1.41	1.47	1.49	1.5	1.51	1.52	1.55	1.56	1.47	1.58	1.59	1.53
Forecast											0.6134	0.3879	0.5765	0.7832	0.8639	0.923	0.9686	0.9789	0.9468	1.0316	1.1677	1.325	1.3824	1.4188	1.4215	1.4647	1.4589	1.5214	1.5365	1.4364	1.4062	1.5278	1.653	1.5514	1.4268
Surprise	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-85.33%	+0.54%	+45.71%	+18.74%	+31.96%	+25.68%	+3.24%	+19.52%	+7.73%	+6.63%	-7.51%	+1.13%	+2.00%	+3.61%	+4.82%	+2.41%	+3.50%	-0.09%	+0.88%	+8.60%	+4.54%	+3.42%	-3.81%	-1.38%	0.00%

OZKAP

OZKAP fundamentals

OZKAP Q1 2026 Earnings Preview

Earnings Call

You can ask Aime

OZKAP

OZKAP fundamentals

OZKAP Q1 2026 Earnings Preview

Earnings Call

OZKAP Earnings Call Summary for Q1/2026Upcoming8:30 AM on Apr 22, 2026

OZKAP Earnings Call Summary for Q4/20258:30 AM on Jan 21, 2026

OZKAP Earnings Call Summary for Q3/20258:30 AM on Oct 17, 2025

OZKAP Earnings Call Summary for Q2/20258:30 AM on Jul 18, 2025

OZKAP Earnings Call Summary for Q1/20258:30 AM on Apr 17, 2025

You can ask Aime